Stocks clawed back much of their early losses and ended mixed on Wall Street Monday. The S&P 500 slipped less than 0.1% and the Nasdaq rose 0.5%. The subdued opening to the week follows several choppy weeks as investors continue to gauge the economy’s recovery and the risks of rising inflation. On Thursday investors will get more information on how much consumer prices rose last month. Technology stocks, banks, and industrial companies pulled the broader market lower, the AP reports. Health care companies made solid gains, as did cruise line operators. The S&P 500 fell 3.37 points to 4,226.52. The Dow Jones Industrial Average fell 126.15 points, or 0.4%, to 34,630.24. The Nasdaq rose 67.23 points to 13,881.72.
Biogen soared 40.2% for the biggest gain in the S&P 500 after the Food and Drug Administration said it approved the company's drug for treating Alzheimer's disease. Biogen's drug is the first Alzheimer's disease treatment approved by the FDA in nearly 20 years. Moderna rose 7.9% after it sought a regulatory authorization in Europe to let adolescents receive its COVID-19 vaccine. US Concrete jumped 29.1% after construction materials company Vulcan Materials said it would buy the company. Cruise line operators made some of the strongest gains after several companies announced or confirmed plans to start sailing again this summer. Norwegian Cruise Line rose 2.7% and Carnival rose 0.9%.
(More
stock market stories.)
,
uBlock 
,
and
Ghostery 
)
